Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 3:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Not Applicable
1 (33.3%)RenalGuard System for Prevention of Contrast Induced Nephropathy
Phase 3
- Conditions
- Radiographic Contrast Agent Nephropathy
- First Posted Date
- 2014-01-08
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Hospital Sao Lucas da PUCRS
- Target Recruit Count
- 210
- Registration Number
- NCT02029820
- Locations
- 🇧🇷
Hospital São Lucas -PUCRS, Serviço de Hemodinâmica, Porto Alegre, RS, Brazil
Safety and Efficacy of the Percutaneous Intervention Performed With Devices of a Single-brand
Not Applicable
Completed
- Conditions
- Atherosclerotic Heart DiseaseCoronary Heart Disease
- First Posted Date
- 2012-07-03
- Last Posted Date
- 2012-07-04
- Lead Sponsor
- Hospital Sao Lucas da PUCRS
- Target Recruit Count
- 84
- Registration Number
- NCT01632501
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy
- First Posted Date
- 2010-07-29
- Last Posted Date
- 2014-02-19
- Lead Sponsor
- Hospital Sao Lucas da PUCRS
- Target Recruit Count
- 301
- Registration Number
- NCT01172353
- Locations
- 🇧🇷
São Lucas Hospital - PUCRS University, Porto Alegre, RS, Brazil
News
No news found